Erratum to Oral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats [Environmental Toxicology and Chemistry, 32 (2013) 577-584] DOI: 10.1002/etc.2105];Oral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats

Environmental Toxicology and Chemistry

Volumn 32, Issue 3, 2013, Pages 577-584

  Rutgersson, Carolin ^a   Gunnarsson, Lina ^a   Fick, Jerker ^b   Kristiansson, Erik ^a,c   Larsson, D G Joakim ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Blood serum screening; Global hepatic gene expression; Pharmaceutical production; Residual active pharmaceutical ingredient; Wastewater

Indexed keywords

ANTIBIOTICS; AQUATIC ORGANISMS; BIOMARKERS; BLOOD; DIAGNOSIS; EFFLUENT TREATMENT; POLYMERASE CHAIN REACTION; POTABLE WATER; RATS; SEWAGE; SUPPLY CHAINS; TRANSCRIPTION; WASTEWATER; WASTEWATER TREATMENT; WATER POLLUTION;

ACTIVE PHARMACEUTICAL INGREDIENTS; ANTIBIOTIC RESISTANCE GENES; BLOOD SERUM; CONTAMINATED SURFACES; HEPATIC GENE EXPRESSIONS; MICROBIAL COMMUNITIES; PHARMACEUTICAL PRODUCTION; QUANTITATIVE POLYMERASE CHAIN REACTION;

EFFLUENTS;

ANTIBIOTIC AGENT; INDUSTRIAL EFFLUENT;

ANTHROPOGENIC EFFECT; AQUATIC ORGANISM; BIOINDICATOR; BIOMARKER; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; EFFLUENT; EMERGENCE; FLUVIAL DEPOSIT; GENE EXPRESSION; INDUSTRIAL WASTE; MICROBIAL COMMUNITY; PHARMACEUTICAL INDUSTRY; POLLUTION EFFECT; POLLUTION EXPOSURE; RODENT; SERUM; TOXICITY TEST; WASTEWATER; WATER POLLUTION; WEIGHT;

ACUTE TOXICITY; ADVERSE OUTCOME; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; ECOTOXICOLOGY; MALE; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SERUM; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION;

ANDHRA PRADESH; HYDERABAD [ANDHRA PRADESH]; INDIA; PATANCHERU;

EID: 84873977221     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.2208     Document Type: Erratum

References (30)

1. Larsson DGJ, de Pedro C, Paxéus N. 2007. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148:751-755.
2. Li D, Yang M, Hu J, Ren L, Zhang Y, Li K. 2008. Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ Toxicol Chem 27:80-86.
3. Li D, Yang M, Hu J, Zhang Y, Chang H, Jin F. 2008. Determination of penicillin G and its degradation products in a penicillin production wastewater treatment plant and the receiving river. Water Res 42:307-317.
4. Fick J, Söderström H, Lindberg RH, Phan C, Tysklind M, Larsson DGJ. 2009. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 28:2522-2527.
5. Larsson DGJ, Fick J. 2009. Transparency throughout the production chain-A way to reduce pollution from the manufacturing of pharmaceuticals? Regul Toxicol Pharmacol 53:161-163.
6. Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, Esposito K, Stinson B. 2010. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol 44:4910-4916.
7. Sim WJ, Lee JW, Lee ES, Shin SK, Hwang SR, Oh JE. 2011. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82:179-186.
8. Carlsson G, Örn S, Larsson DGJ. 2009. Effluent from bulk drug production is toxic to aquatic vertebrates. Environ Toxicol Chem 28:2656-2662.
9. Gunnarsson L, Kristiansson E, Rutgersson C, Sturve J, Fick J, Förlin L, Larsson DGJ. 2009. Pharmaceutical industry effluent diluted 1:500 affects global gene expression, cytochrome P450 1A activity, and plasma phosphate in fish. Environ Toxicol Chem 28:2639-2647.
10. Beijer K, Gao K, Jönsson ME, Larsson DGJ, Brunström B, Brandt I. 2013. Effluent from drug manufacturing affects cytochrome P450 1 regulation and function in fish. Chemosphere 90:1149-1157.
11. Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdegård B, Söderström H, Larsson DGJ. 2011. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 6:e17038.
12. Greenpeace. 2004. State of community health at Medak district. Bangalore, India.
13. Cox S. 2008. Side effects may be severe. In Sick Planet-Corporate Food and Medicine. Pluto, London, UK, pp 34-46.
14. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, Brady L, Browne LJ, Calvin JT, Day GJ, Breckenridge N, Dunlea S, Eynon BP, Furness LM, Ferng J, Fielden MR, Fujimoto SY, Gong L, Hu C, Idury R, Judo MS, Kolaja KL, Lee MD, McSorley C, Minor JM, Nair RV, Natsoulis G, Nguyen P, Nicholson SM, Pham H, Roter AH, Sun D, Tan S, Thode S, Tolley AM, Vladimirova A, Yang J, Zhou Z, Jarnagin K. 2005. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 119:219-244.
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5:R80.
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
17. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article 3.
18. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate-A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57:289-300.
19. Grabic R, Fick J, Lindberg RH, Fedorova G, Tysklind M. 2012. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry. Talanta 100:183-195.
20. Fielden MR, Brennan R, Gollub J. 2007. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol Sci 99:90-100.
21. Liguori MJ, Blomme EA, Waring JF. 2008. Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: Comparison of primary human hepatocytes to HepG2 cells. Drug Metab Dispos 36:223-233.
22. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. 2011. DrugBank 3.0: A comprehensive resource for omics research on drugs. Nucleic Acids Res 39:D1035-D1041.
23. Brown JN, Paxéus N, Förlin L, Larsson DGJ. 2007. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ Toxicol Pharmacol 24:267-274.
24. Fick J, Lindberg RH, Parkkonen J, Arvidsson B, Tysklind M, Larsson DGJ. 2010. Therapeutic levels of levonorgestrel detected in blood plasma of fish: Results from screening rainbow trout exposed to treated sewage effluents. Environ Sci Technol 44:2661-2666.
25. Jones OA, Lester JN, Voulvoulis N. 2005. Pharmaceuticals: A threat to drinking water? Trends Biotechnol 23:163-167.
26. Zuccato E, Calamari D, Natangelo M, Fanelli R. 2000. Presence of therapeutic drugs in the environment. Lancet 355:1789-1790.
27. World Health Organization. 2012. Pharmaceuticals in drinking-water. Geneva, Switzerland
28. Rowney NC, Johnson AC, Williams RJ. 2009. Cytotoxic drugs in drinking water: A prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environ Toxicol Chem 28:2733-2743.
29. Larsson DGJ. 2010. Release of active pharmaceutical ingredients from manufacturing sites-Need for new management strategies. Integr Environ Assess Manag 6:184-186.
30. Boxall AB, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, Innes E, Ostapyk K, Staveley JP, Verslycke T, Ankley GT, Beazley KF, Belanger SE, Berninger JP, Carriquiriborde P, Coors A, Deleo PC, Dyer SD, Ericson JF, Gagne F, Giesy JP, Gouin T, Hallstrom L, Karlsson MV, Larsson DGJ, Lazorchak JM, Mastrocco F, McLaughlin A, McMaster ME, Meyerhoff RD, Moore R, Parrott JL, Snape JR, Murray-Smith R, Servos MR, Sibley PK, Straub JO, Szabo ND, Topp E, Tetreault GR, Trudeau VL, Van Der Kraak G. 2012. Pharmaceuticals and personal care products in the environment: What are the big questions? Environ Health Perspect 120:1221-1229.